In previous work, we showed the clinical significance of 16 candidate molecular biomarkers (AZGP1, BTG2, CBX2, CNTNAP2, DNALI1, LOC389033, NME5, PIP, S100A8, SCUBE2, SERPINA11, STC2, STK32B, SUSD3, UBE2C, and WHSC1L1) in invasive breast carcinoma [14,15,23]. Here, S100A8 is linked to invasive breast carcinoma.